Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.
We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.
Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.
Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.
Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.
We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.
Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.
Our trusted Pharma Intelligence brands
Pink Sheet
By Neena Brizmohun 25 May 2017
Companies won’t necessarily lose their place on the European Medicines Agency’s priority medicines scheme if a competing product gets to market first.
Pink Sheet
By Brenda Sandburg 25 May 2017
Referencing opioids and suicidal thoughts is not sufficient, US regulators say; letter comes as Orexigen has seen an upsurge in Contrave prescriptions.
Topic FDA
Scrip
By Mandy Jackson 25 May 2017
Bioverativ revealed its first transaction since spinning out from Biogen with the acquisition of True North for $400m plus up to $425m in milestone payments.
Topic Business strategies
Scrip
By Alex Shimmings 25 May 2017
The Pharmaceutical and Biotech industries’ R&D performance can be measured in a number of ways. View the infographic here.
Topic Research
Scrip
By Lucie Ellis 25 May 2017
Scrip asks industry whether the promise of biosimilars producing substantial cost-savings is a sustainable model to help healthcare systems afford the next wave of expensive biologics.
Topic Biosimilars
Pink Sheet
By Sue Sutter 23 May 2017
Tyrosine kinase inhibitor has an effect in adjuvant breast cancer but ‘there remains some uncertainty regarding the true magnitude of the treatment effect,”...
Topic Drug review
Pink Sheet
By Michael Cipriano 23 May 2017
FDA reviewers disagree with Emmaus' extrapolation methods for holes in data for its L-glutamine ahead of May 24 Oncologic Drugs Advisory Committee meeting.
Topic Clinical trials
Medtech Insight
By Reed Miller 22 May 2017
Boston Scientific's repositionable, mechanically expanded Lotus transcatheter aortic valve performed better than Medtronic's CoreValve for the primary composite effectiveness endpoint in the REPRISE III trial, according to results presented at the EuroPCR meeting in Paris.
Topic Clinical trials Research
Meddevicetracker
22 May 2017
Meddevicetracker Weekly News Write-Up, March 27, 2017.
Topic Medtech weekly roundup
Medtech Insight
By Amanda Maxwell 22 May 2017
The number of notified bodies operating under the EU's current medical device directives continue to decline, and that trend is expected to persist with the new regulations entering into force.
Scrip
By Sten Stovall 22 May 2017
Shire's CEO is savoring a personal victory after Phase III data for lanadelumab in acute HAE replicated impressive Phase Ib trial results that underpinned his 2015 decision to buy Dyax.
Topic Business strategies
Scrip
By Mandy Jackson 22 May 2017
Biomedtracker's review of ASCO abstracts revealed several drugs to watch outside of the immuno-oncology space at the annual cancer conference in Chicago.
Topic Clinical trials
Meddevicetracker, Medtrack
By Edward Stopke 22 May 2017
Meddevicetracker weekly round up
Pink Sheet
By Ferdous Al-Faruque 19 May 2017
In a podcast interview Robert Califf discusses his advisory role within Verily and his hopes that new FDA Commissioner Scott Gottlieb would stand up to any 'whimsical directives' from President Trump.
Topic FDA
Pink Sheet
By Maureen Kenny 19 May 2017
Competing cities that want to host the European Medicines Agency (in light of Brexit), are working hard to come up with a determining factor that will make them the obvious choice.
Topic Brexit
Medtech Insight
24 May 2017
Medtech Insight
24 May 2017
Medtech Insight
24 May 2017
Medtech Insight
24 May 2017
Medtech Insight
24 May 2017
Medtech Insight
23 May 2017
Medtech Insight
23 May 2017
Medtech Insight
23 May 2017
Medtech Insight
23 May 2017
Medtech Insight
23 May 2017
Medtech Insight
22 May 2017
Medtech Insight
22 May 2017
Medtech Insight
22 May 2017
Medtech Insight
22 May 2017
Medtech Insight
22 May 2017
The industry’s gold standard for clinical trials intelligence, made by experts for experts
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Timely news and in-depth insight. Essential for anyone making commercial decisions in the pharmaceutical industry.
Key benefits:
29 Nov 2017
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
